Abstract Context Prostate cancer (PCa) is the most common cancer in the adult male, and
benign prostatic hyperplasia (BPH) represents the most frequent urologic diagnosis in …

CONTEXT: Metabolic syndrome (MetS), a cluster of several metabolic abnormalities with a
high socioeconomic cost, is considered a worldwide epidemic. Recent epidemiologic and …

Several different stimuli may induce chronic prostatic inflammation, which in turn would lead
to tissue damage and continuous wound healing, thus contributing to prostatic enlargement …

Prostatic hyperplasia (PH) is a common urologic disease that affects mostly elderly men. PH
can be classified as benign prostatic hyperplasia (BPH), or prostate cancer (PCa) based on …

Benign prostatic hyperplasia (BPH) and prostate cancer are among the most common
diseases of the prostate gland and represent significant burdens for patients and health-care …

Prostate cancer and benign prostatic hyperplasia are common genitourinary diseases in
aging men. Both pathologies may coexist and share numerous similarities, which have …

Importance There is evidence that 5α-reductase inhibitors (5-ARIs), a standard treatment of
benign prostate hyperplasia, are associated with a decrease in the incidence of prostate …

Benign Prostatic Hyperplasia and the Risk of Prostate Cancer... : Medicine Benign Prostatic
Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of …

The human microbiota shows pivotal roles in urologic health and disease. Emerging studies
indicate that gut and urinary microbiomes can impact several urological diseases, both …

Prediction of prostate cancer in primary care is typically based upon serum total prostate-
specific antigen (tPSA) and digital rectal examination results. However, these tests lack …